SE8201184L - Forening med antitussiv verkan - Google Patents

Forening med antitussiv verkan

Info

Publication number
SE8201184L
SE8201184L SE8201184A SE8201184A SE8201184L SE 8201184 L SE8201184 L SE 8201184L SE 8201184 A SE8201184 A SE 8201184A SE 8201184 A SE8201184 A SE 8201184A SE 8201184 L SE8201184 L SE 8201184L
Authority
SE
Sweden
Prior art keywords
antitusive
association
effect
theophyllin
propanediol
Prior art date
Application number
SE8201184A
Other languages
English (en)
Other versions
SE440503B (sv
Inventor
V Pestellini
M Ghelardoni
D Giannotti
A Meli
C A Maggi
Original Assignee
Menarini Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Sas filed Critical Menarini Sas
Publication of SE8201184L publication Critical patent/SE8201184L/sv
Publication of SE440503B publication Critical patent/SE440503B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8201184A 1981-02-25 1982-02-25 3-(4-fenyl-1-piperazino-1-yl)-1,2-propandiol-3-(teofyllin-7-yl)-1-propansulfonat, forfarande for framstellning av denna samt lekemedel med antitussiv verkan SE440503B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8109343A IT1210639B (it) 1981-02-25 1981-02-25 Prodotto: 3(4-fenil1piperazinio-1-il)-1,2-propandiolo 3(teofillin-7-il)-1propansolfonato,utilizzabile in terapia,e relativo procedimento di fabbricazione

Publications (2)

Publication Number Publication Date
SE8201184L true SE8201184L (sv) 1982-08-26
SE440503B SE440503B (sv) 1985-08-05

Family

ID=11128724

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8201184A SE440503B (sv) 1981-02-25 1982-02-25 3-(4-fenyl-1-piperazino-1-yl)-1,2-propandiol-3-(teofyllin-7-yl)-1-propansulfonat, forfarande for framstellning av denna samt lekemedel med antitussiv verkan

Country Status (18)

Country Link
US (1) US4372958A (sv)
JP (1) JPS57188589A (sv)
AT (1) AT380881B (sv)
BE (1) BE892271A (sv)
CA (1) CA1192549A (sv)
CH (1) CH651043A5 (sv)
DE (1) DE3205149A1 (sv)
DK (1) DK148687C (sv)
ES (1) ES8302680A1 (sv)
FR (1) FR2500455A1 (sv)
GB (1) GB2093445B (sv)
GR (1) GR76060B (sv)
IT (1) IT1210639B (sv)
LU (1) LU83962A1 (sv)
NL (1) NL8200746A (sv)
PT (1) PT74463B (sv)
SE (1) SE440503B (sv)
YU (1) YU44007B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1203721B (it) * 1983-12-29 1989-02-23 Dompe Farmaceutici Spa Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono
IT1217950B (it) * 1988-06-28 1990-03-30 Dott Formenti Ind Chimica E Fa Sali di (r,s) 3 (4 fenil 1 piperazinil) 1,2 propandtolo
IT1231158B (it) * 1989-07-20 1991-11-19 Dompe Farmaceutici Spa Procedimento per la risoluzione ottica della dropropizina.
DE3938123A1 (de) * 1989-11-16 1991-05-23 Diehl Gmbh & Co Treibladungsanzuender
IT1318651B1 (it) * 2000-07-28 2003-08-27 Dompe Spa Sintesi di (+-)1,3-diossolani e loro risoluzione ottica.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3163649A (en) * 1964-12-29 Substituteb phenyl-piperazine
GB938646A (en) * 1961-03-16 1963-10-02 Henri Morren New piperazine derivatives
FR1384693A (fr) * 1963-10-08 1965-01-08 Electrochimie Soc Procédé de préparation d'esters méthallyliques
FR1554628A (sv) * 1967-05-23 1969-01-24

Also Published As

Publication number Publication date
YU44007B (en) 1990-02-28
ATA59982A (de) 1985-12-15
NL8200746A (nl) 1982-09-16
PT74463B (en) 1983-08-24
CH651043A5 (it) 1985-08-30
GR76060B (sv) 1984-08-03
CA1192549A (en) 1985-08-27
GB2093445B (en) 1985-02-27
US4372958A (en) 1983-02-08
BE892271A (fr) 1982-06-16
AT380881B (de) 1986-07-25
IT8109343A0 (it) 1981-02-25
JPH0333715B2 (sv) 1991-05-20
LU83962A1 (fr) 1982-07-08
PT74463A (en) 1982-03-01
ES509850A0 (es) 1983-02-01
FR2500455A1 (fr) 1982-08-27
DK79982A (da) 1982-08-26
YU41282A (en) 1987-10-31
DK148687B (da) 1985-09-02
JPS57188589A (en) 1982-11-19
SE440503B (sv) 1985-08-05
FR2500455B1 (sv) 1984-04-27
GB2093445A (en) 1982-09-02
DE3205149A1 (de) 1982-11-11
ES8302680A1 (es) 1983-02-01
DK148687C (da) 1986-04-28
IT1210639B (it) 1989-09-14
DE3205149C2 (sv) 1991-04-18

Similar Documents

Publication Publication Date Title
EP0028557A3 (en) Syringe functioning with the assistance of an external source of energy
DK554084A (da) 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol
NO146820C (no) Fremgangsmaate for aa opploese bariumsulfatavsetninger i en broenn som trenger gjennom en underjordisk formasjon, samt en vandig opploesning for anvendelse derved
DK519280A (da) Fastgoerelsesorgan forsynet med en laas
NL186432B (nl) Inrichting voor therapie met hoogfrequente straling.
NO871053L (no) Anvendelse av substituerte n-triklormetyltiodikarboksimider i kombinasjon med n,n[-substituerte bis-(2,4-diamino-s-triazin-6-yl)-oligosulfider i vulkaniserbare kautsjukblandinger og slike kautsjukblandinger.
FR2348568A1 (fr) Lampe d'irradiation
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
SE8201184L (sv) Forening med antitussiv verkan
IT8348560A0 (it) Impiego di un derivato della epirosuccinimmide nel trattamento della demenza del tipo alzheimer
KR880005928A (ko) 에브셀렌(Ebselen)의 새로운 의약적 용도
DE69032000T2 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69023459T2 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
DE3886959T2 (de) 1,2-Propandiolderivate.
NO870623L (no) Fluorborsyresalt av et substituert morfolin og trebeskyttelsesmiddel.
FI851365L (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
DE3262037D1 (de) 17-cyclopropylmethyl-3-hydroxy-14-methoxy 7 alpha-methylmorphinan-6-one
IT7822934V0 (it) Dispositivo atto a consentire la chiusura di una serratura del tipo a combinazione numerica, anche quando non e' impostata, nella serratura, la detta combinazione numerica.
SE7906940L (sv) Laktatsalter av 1 - och d,1-glaucin
DD135657A1 (de) Tragbare bestrahlungseinrichtung mit neutronenquelle
ES237680Y (es) Disposicion perfeccionada en el contrapunto de un torno.
ES235337Y (es) Torno portatil perfeccionado.
SE7906729L (sv) Anjonbytarharts samt sett for dess framstellning

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8201184-2

Effective date: 19920904

Format of ref document f/p: F